v3.24.1.u1
Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities:    
Net income (loss) $ 176,498 $ 1,146
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 174,933 168,812
Deferred income taxes 16,774 (162)
Stock-based compensation expense 14,369 14,710
Amortization of debt issuance costs 10,350 8,763
Loss on debt financing transactions 1,561 12,236
Provision for credit losses 87 (544)
Change in derivatives fair value 17,914 (23,046)
Property charges and other 19,261 33,072
Increase (decrease) in cash from changes in:    
Receivables, net 44,352 (11,048)
Inventories, prepaid expenses and other (21,728) (7,288)
Customer deposits (53,147) (13,316)
Accounts payable and accrued expenses (86,130) (13,844)
Net cash provided by operating activities 315,094 169,491
Cash flows from investing activities:    
Capital expenditures, net of construction payables and retention (97,702) (124,466)
Investments in unconsolidated affiliate (69,928) 0
Purchase of intangible and other assets (15) (7,741)
Proceeds from sale of assets and other 226 257
Net cash used in investing activities (167,419) (131,950)
Cash flows from financing activities:    
Proceeds from issuance of long-term debt 412,000 1,200,000
Repayments of long-term debt (956,666) (1,018,973)
Repurchase of common stock (11,374) (10,834)
Proceeds from exercise of stock options 1,017 0
Distribution to noncontrolling interest (5,996) (4,502)
Dividends paid (27,959) (175)
Finance lease payments (5,056) (5,410)
Payments for financing costs (5,843) (31,330)
Other (4,486) (7,773)
Net cash (used in) provided by financing activities (604,363) 121,003
Effect of exchange rate on cash, cash equivalents and restricted cash (2,375) (2,567)
Cash, cash equivalents and restricted cash:    
(Decrease) increase in cash, cash equivalents and restricted cash (459,063) 155,977
Balance, beginning of period 2,969,412 3,782,990
Balance, end of period $ 2,510,349 $ 3,938,967